共 50 条
- [1] Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2608 - 2612Lacombe, PDeschênes, DDubé, DDubé, LGallant, MMacdonald, DMastracchlo, APerrier, HCharleson, SHuang, ZLaliberté, FLiu, SMancini, JAMasson, PSalem, MStyhler, AGirard, Y
- [2] Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 5266 - 5269Lacombe, PatrickChauret, NathalieClaveau, DavidDay, StephenDeschenes, DenisDube, DanielGallant, MichelGirard, YvesHuang, ZhengLaliberte, FranceLevesque, Jean-FrancoisLiu, SusanaMacdonald, DwightMancini, Joseph A.Masson, PaulNicholson, Donald W.Nicoll-Griffith, Deborah A.Salem, MyriamStyhler, AngelaYoung, Robert N.
- [3] 8-Arylquinolines derivatives as potent PDE IV inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2672 - U2672Lacombe, PDeschênes, DDubé, DDubé, LGallant, MMacdonald, DMastracchio, APerrier, HHuang, ZLaliberté, FMancini, JAMasson, PSalem, MNicholson, DWGirard, Y
- [4] The design and synthesis of bioavailable PDE IV inhibitors.[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 115 - MEDICox, PJFenton, GNewton, CGPage, KPalfreyman, MNRatcliffe, AJSmith, GFSouness, JEStuttle, KAJThurairatnam, S
- [5] The novel potent and selective PDE IV inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 91 - MEDIUkita, TSugahara, MTerakawa, YKikkawa, HWada, K
- [6] Synthetic studies on selective type IV phosphodiesterase (PDE IV) inhibitors.[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 245 - MEDITakayama, KIwata, MOkamoto, YAoki, MNiwa, AIsomura, Y
- [7] Design and synthesis of 2-substituted-3,4-dialkoxy-benzamides as PDE-IV inhibitors.[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U215 - U215Haddad, SNMaye, PVGerster, JFBirmachu, WScribner, LRBulbulian, BJ
- [8] Synthetic studies on selective type IV phosphodiesterase (PDE IV) inhibitors. II[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U874 - U874Hisamichi, HTakayama, KIwata, MKubota, HKawano, NAoki, MIsomura, Y
- [9] Discovery of potent and selective orally bioavailable β-substituted phenylalanine derived dipeptidyl peptidase IV inhibitors.[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U218 - U218Edmondson, SDMastracchio, ADuffy, JLEiermann, GJHe, HBLeiting, BLeone, JFLyons, KAMakarewicz, AMPatel, RAPetrov, AWu, JKThornberry, NAWeber, AE
- [10] Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues[J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (46) : 8082 - 8091Zhmurov, Petr A.Sukhorukov, Alexey YuChupakhin, Vladimir I.Khomutova, Yulia V.Ioffe, Sema L.Tartakovsky, Vladimir A.